Tonix Pharmaceuticals Holding (TNXP) Total Liabilities (2010 - 2026)

Tonix Pharmaceuticals Holding has reported Total Liabilities for 17 years, with the latest figure at $31.8 million in Q2 2026.

• On a quarterly basis, Total Liabilities rose 64.31% year-over-year to $31.8 million in Q2 2026; TTM through Jun 2026 was $31.8 million, a 64.31% increase from a year earlier, with the FY2025 full-year figure at $32.0 million, up 37.24% from the prior year.
• Total Liabilities was $31.8 million for Q2 2026 at Tonix Pharmaceuticals Holding, up from $30.8 million in the prior quarter.
• The five-year high for Total Liabilities was $48.9 million in Q4 2023, with the low at $12.5 million in Q1 2025.
• Average Total Liabilities over 5 years is $22.9 million, with a median of $20.1 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2025: Total Liabilities surged 164.38% in 2023, then sank 54.14% in 2025.
• Over 5 years, Total Liabilities stood at $18.5 million in 2022, then soared by 164.38% to $48.9 million in 2023, then plunged by 52.32% to $23.3 million in 2024, then jumped by 37.24% to $32.0 million in 2025, then fell by 0.67% to $31.8 million in 2026.
• The last three Total Liabilities figures came in at $31.8 million (Q2 2026), $30.8 million (Q1 2026), and $32.0 million (Q4 2025), per Business Quant data.